Introduction
============

Life expectancy has increased substantially during past few decades, mainly attributable to advancements of health care and lifestyle. The ensuing upward shift in demographic distribution has resulted in a rising prevalence of aging-related diseases, such as dementia. According to the report in [@B117], dementia affects approximately 46.8 million people worldwide. AD, as the most prevalent type of senile dementia by far, accounts for 60--80% of all cases with dementia ([@B117]). The prevalence of AD is estimated to quadruple and intensive health care will be needed for 43% of these patients by 2050 ([@B11]).

Despite of the heavy public disease burden of AD, there is no effective treatment for AD. Advances in the effective treatment and prevention of AD have been hampered by challenges in diagnosing the disease at the preclinical phase, in which subjects are still asymptomatic in clinical settings but may have subtle evidence of early cognitive deficits in the context of neuropathology specific to AD ([@B133]). Currently, diagnosis was primarily based on cognitive assessments among patients with symptomatic cognitive and behavior deficits ([@B34]). Studies suggested that measurable changes in PET, MRI and CSF biomarkers occurred predates the onset of clinical symptoms ([@B8]). Unfortunately, these are costly and/or invasive procedures that are not appropriate for screening at a population level.

As a projection of the CNS via the optic nerve, the retina has been described as a "window to the brain" and investigated intensively the potential of serving as a marker for AD ([@B52]; [@B93]). Low cost, easy accessibility and non-invasive features make retina tests suitable for large-scale population screening and investigations of preclinical AD. Furthermore, a number of novel approaches in retina imaging, such as OCT, have been developed and made it possible to visualize lesions and changes of the retina at a very fine resolution.

In this review, we outline the background for AD to accelerate the adoption of retina imaging for the diagnosis and management of AD in clinical practice. Then, we focus on recent findings on the application of retina imaging to investigate AD and provide suggestions for future research directions.

Challenges for Early Detection of AD
====================================

In 1906, Alois Alzheimer was credited with identifying the first condition of dementia, which was later to carry his name as AD. AD is a progressive neurodegenerative disease, in which synaptic and neuronal loss([@B139]; [@B115]) lead to irreversible deterioration in memory loss, cognitive impairment and behavioral deficits([@B47]). Well-known pathological hallmark related to AD is the propensity of proteins to form toxic oligomers and fibrils ([@B63]). The two key proteins related to AD are Aβ peptide and hyper-phosphorylated tau ([@B96]; [@B49]). Aβ peptide is a small peptide deprived from its parent molecule, the amyloid-β precursor protein (AβPP), and accumulates of Aβ into extracellular amyloid senile plaques ([@B115]). Hyper-phosphorylated tau is a MAP that accumulates intraneuronally to form neurofibrillary tangles ([@B99]). Consistent evidences have demonstrated that neuropathologial changes, mainly the accumulation of Aβ and tau, predate the emergence of clinical symptoms by as long as 15--20 years, emphasizing the potential of developing methods for early diagnosis ([@B60]).

According to the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association criteria ([@B97]), the first definition for diagnosis of AD is relied on neuropathological analysis of brain tissue, obtained by biopsy or autopsy, for the accumulation of Aβ peptides and tau protein. In the following decades, advances in the early diagnosis of AD have been hampered by challenges in differentiating earliest stage of AD with age-related cognitive deficit and other forms of dementia. Furthermore, AD is currently diagnosed by cognitive assessments among patients with symptomatic cognitive and behavior deficits ([@B34]), which is usually the advanced stage and irreversible to treatment. Despite of enormous financial and scientific efforts, the treatment of AD has remained symptom-driven and no single disease-modifying therapy for AD has been approved. So far, it has been documented the high failure rate -- nearly 90% -- of clinical drug trials for AD. One of possible reasons for the high failure rate might be the inclusion of patients with the uncertainty diagnosis and/or late-stage disease ([@B134]; [@B64]; [@B66]). Two phase 3 clinical trials([@B33]; [@B123]) investigated the anti-Aβ antibody's effect on the treatment of mild-to-moderate AD. Neither study showed a significant benefit of solanezumab ([@B33]) or bapineuzumab ([@B123]) for primarily designated outcomes. However, with sub-analysis of participants with mild AD, half of the prespecified endpoints was met and cognitive deficits were slowed by 34% ([@B132]), suggesting the therapy may be effective in treating the early course of AD. A recent phase 1b randomized trial of monthly intravenous infusion of the anti-Aβ antibody abucanumab in patients with prodromal or mild AD did not have enough power to detect clinical change, however, *post hoc* analysis suggested the reduction of Aβ burden in brain and a stabilization of cognitive decline based on Clinical Dementia Rating-Sum of Boxes and Mini Mental State Examination scores ([@B131]). Modeling has suggested that interventions aimed at clearing Aβ accumulation may be sufficient to delay the onset of clinically manifest AD, reduce the incidence and the progression of AD if started in the early stages of AD ([@B10]). These findings again stress the importance of early detection of AD.

The increasing global prevalence of AD, along with the urgent to prevent and treat the disease before the irreversible damage to the brain, calls for a sensitive and specific screening strategy to identify individuals at high risk of AD before cognitive symptoms arise. A large number of novel methods for diagnosis of AD have been developed during the past decades. Non-invasive neuroimaging tools such as MRI can detect subclinical structural brain changes (e.g., atrophy) related to the future risk of AD. However, due to limited spatial resolution, MRI measures may not be able to detect subtle changes at the early stages. Although specific neuropathology biomarkers, such as the detection of Aβ and tau accumulation measured by PET imaging ([@B64]; [@B35]) and in CSF ([@B6]; [@B39]) can be detected predates the onset of clinical symptoms and have shown high specificity in confirming AD pathophysiology ([@B8]; [@B34]), the high cost, narrow isotope availability of PET probes and invasive characteristics of CSF biomarkers limited their broad usages.

Therefore, additional tools for detection of AD are needed, with the aim of changing from an exclusionary approach to an accuracy diagnosis, from late-stage symptomatic diagnosis to the subclinical pathology detection, and using in large-scale population screening to identify individuals at high risk of developing AD. As the projection of CNS, the retina has attracted researchers' attention to study AD and its pathology. A large number of studies have employed retina imaging for early detection and large-scale population screening of AD, and considerable progresses have been achieved in recent years.

The Retina -- A "Window to AD"
------------------------------

As an extension of the CNS, the retina and optic nerve share many features in terms of embryological origin, anatomy, response to injury, immunology and physiological characteristics, with the brain ([@B90]). The retina and optic nerve originate from the diencephalon during embryonic development, and therefore are considered as an extension of the CNS. Photoreceptor cells of the retina capture light and initiate neuronal signals that eventually reach the RGCs. The optic nerve composed of the axons of RGCs passes the visual information to the higher visual processing centers in the brain. RGCs show the typical patterns of CNS neurons and comprise a cell body, dendrites and an axon. Similar to all fiber tracts of CNS, the optic nerve is myelinated as they leave the eyes. Insult to the optic nerve leads to degeneration of the axons, myelin damage and inducing a neurotoxic condition, which are also observed in other CNS axons ([@B38]; [@B130]; [@B27]; [@B150]; [@B85], [@B86]). After injury, similar limited regeneration environment exists in the retina, optic nerve and other CNS compartments. The eye and the brain normally maintain strict interactions with immune system, and both are immune-privileged organs. Furthermore, ocular inner BRB resembles the BBB strongly with respect to structures, characteristics and mechanisms ([@B70]).

Retinal Changes and AD
======================

Given these strong connections between the brain and the retina, it has been indicated that neurodegenerative disease, such as AD, may also lead to similar pathology in RGCs and optic nerve. The retina and brain are directly connected by axons of the optic nerve, which facilitate transportation of APP synthesized in RGCs in small transport vesicles ([@B101]). Furthermore, retinal neurons and glia express proteins that have participated in the amyloid cascade (e.g., BACE1, γ-secretase, APOE) ([@B15]; [@B87]; [@B143]). Several studies verified the presence of classical biomarkers of AD, Aβ and tau, within the retina and optic nerve at the molecular level ([@B44]; [@B79]). Retinal Aβ deposits triggers breakdown of RPE tight junction ([@B110]) and integrity of the blood-retina barrier ([@B30]), increases reactive oxygen species production ([@B12]), and activates complement by upregulating factor B ([@B145]). The crucial roles of Tau played in retina include regulating the cytoskeletal and axonal transport in retinal neurons, increasing Aβ accumulation and affecting cell survival signaling in the retina ([@B59]). Therefore, the toxic effects of these deposits include the apoptosis of the RGCs, thinning of the RNFL, morphological changes in the optic nerve, and other retinal structural and functional impairment of AD patients ([@B58]; [@B142]; [@B55]; [@B29]; [@B62]; [@B107]; [@B104]; [@B114]; [@B111]; [@B43]; [@B124]). Studies using animal models of AD have demonstrated that AβPP and Aβ were accumulated in all six layers of the neuroretina ([@B89]), with the extent proportional to the increasing age of the animal models. Furthermore, animal models have shown that retinal senile plaques were correlated with plaque load in the brain ([@B78]) and were detected prior to the plaque deposition in the brain, implying that Aβ deposition seen in the retina could be an early related sign of AD detection ([@B151]; [@B79]). In addition, hyperphosphorlylated tau has been reported to accumulate in the RNFL of transgenic AD mouse models, which results in disruption of axonal transport and ganglion cell degeneration ([@B44]; [@B13]).

It has been suggested that AD might also be a disease of the neurovascular unit indicated from results of cerebral amyloid angiopathy, focal lesions in brain microcirculation system and strong associations between vascular changes of AD with typical neuronal degenerative changes ([@B152]). The overproduction of Aβ in the retinal vascular increases the mechanical stress to endothelial cell regulation of AβPP, with associated destruction of the vessel walls, leading to changes of vascular diameters and topology ([@B48]). A large body of evidences have also verified potential associations between AD and retinal vascular parameters, both static and dynamic, such as retinal vascular diameters, retinal pulsatility and local arterial PWV ([@B9]; [@B112]; [@B41]; [@B40]; [@B146]). Transgenic animal models of AD have shown Aβ and senile plaques accumulation in retinal vasculature ([@B151]; [@B89]).

Imaging Retina to Study AD
==========================

The visualization of detailed structure and functions of the retina has dramatically improved with the development of modern imaging techniques. This has provided clinicians and researchers with valuable tools for potential early diagnosis and differentiation, monitoring progression, and clinical drug trials of AD (**Table [1](#T1){ref-type="table"}**).

###### 

Summary description of potential retinal imaging techniques to study AD.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Techniques                                      Summary                                                                                                                                                            Main findings                                                                                           High lights                                                                                   Limitation/Future Direction
  ----------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------
  **Structural imaging techniques**                                                                                                                                                                                                                                                                                                                                                                                        

  Ocular fundus                                   Color photograph of retinal surface.                                                                                                                               \(a\) Qualitative: retinopathy, optic neuropathy;\                                                      \(a\) Widely used;\                                                                           \(a\) Weak association;\
                                                                                                                                                                                                                     (b) Retinal vascular caliber: vascular reduction, increasing variability of vessel width;\              (b) Rapid;\                                                                                   (b) Non-specific;\
                                                                                                                                                                                                                     (c) Global geometrical patterns: attenuation of complexity and optimality in the branching geometry;\   (c) Consistent;\                                                                              (c) Longitudinal studies are needed;\
                                                                                                                                                                                                                     (d) Patterns of RNFL abnormalities: diffuse and wedge shape RNFL drop-out;\                             (d) Economic;\                                                                                (d) Efficiency in measurement of retinal vasculature of ultra-wide field ocular fundus need to be established.
                                                                                                                                                                                                                     (e) Increased drusen number, venular width gradient in peripheral retina;\                              (e) Non-invasive;\                                                                            
                                                                                                                                                                                                                     (f) Reduction in arterial fractal dimension in peripheral retina.                                       (f) Novel fully automatically software programs: facilitating a more efficient assessment;\   
                                                                                                                                                                                                                                                                                                                             (g) Non-mydriatic ultra-wide field retinal imaging technology: more comprehensive picture.    

  Optical coherence tomography (OCT)              Near-infrared light penetrates retina; interferometry resolves tissue layers.                                                                                      \(a\) RNFL thinning;\                                                                                   \(a\) Rapid;\                                                                                 \(a\) No visualization of single cell;\
                                                                                                                                                                                                                     (b) Ganglion cell complex atrophy;\                                                                     (b) Consistent;\                                                                              (b) Susceptible to ocular opacity;\
                                                                                                                                                                                                                     (c) Decline in macular thickness and volume;\                                                           (c) Economic;\                                                                                (c) Poor comparability between different instrument;\
                                                                                                                                                                                                                     (d) Reduction in retinal total thickness.\                                                              (d) Non-invasive;\                                                                            (d) Non-specific changes to AD.
                                                                                                                                                                                                                     (e) Signs of optic neuropathy: optic disk atrophy, cupping, and attenuation of neuroretinal rim.        (e) Image registration for precise follow-up imaging;\                                        
                                                                                                                                                                                                                                                                                                                             (f) Eye tracking systems to reduce motion artifacts and noise.                                

  Confocal scanning laser ophthalmoscopy (cSLO)   Confocal laser beam scans of retinal surface.                                                                                                                      \(a\) Significant reduction in the RNFL;\                                                               \(a\) Non-invasive;\                                                                          \(a\) Poor axial resolution;\
                                                                                                                                                                                                                     (b) Reduction in neuroretinal rim;\                                                                     (b) Patient-friendly (less-bright light);\                                                    (b) No visualization of single cell;\
                                                                                                                                                                                                                     (c) Increasing vertical cup-to-disk.                                                                    (c) Larger field of view;\                                                                    (c) Expensive.
                                                                                                                                                                                                                                                                                                                             (d) Reconstruction of three-dimensional structures;\                                          
                                                                                                                                                                                                                                                                                                                             (e) Increasing resolution and contrast;\                                                      
                                                                                                                                                                                                                                                                                                                             (f) Differentiation among neurodegenerative diseases.                                         

  Detection of Apoptotic Retinal Cells (DARC)     Real-time visualization of apoptotic retinal cells.                                                                                                                Detection of increasing number of apoptotic RGCs in AD animal models.                                   \(a\) Non-invasive;\                                                                          \(a\) Healthy dataset of apoptotic cells needs to be established;\
                                                                                                                                                                                                                                                                                                                             (b) Quantifiable;\                                                                            (b) Efficiency in AD patients is needed.
                                                                                                                                                                                                                                                                                                                             (c) Single-cell fluorescence resolution;\                                                     
                                                                                                                                                                                                                                                                                                                             (d) Assessment of treatment effectiveness;\                                                   
                                                                                                                                                                                                                                                                                                                             (e) Screening of new drugs.                                                                   

  **Functional imaging techniques**                                                                                                                                                                                                                                                                                                                                                                                        

  Pattern electroretinogram (PERG)                Using pattern-reversal stimuli and capturing retinal ganglion cell activity.                                                                                       \(a\) Reduction in the amplitude of ERG responses;\                                                     Potential early detection of AD.                                                              \(a\) Quite cumbersome;\
                                                                                                                                                                                                                     (b) Attenuation of the ERG signal.                                                                                                                                                                    (b) Time-consuming.

  Retinal oximetry                                Spectrophotometric fundus imaging to measure oxygen saturation in retinal blood vessels.                                                                           Increasing arteriolar and venular oxygen saturation in MCI and moderate AD patients.                    \(a\) Quick;\                                                                                 \(a\) Pupil dilation is needed;\
                                                                                                                                                                                                                                                                                                                             (b) Safe;\                                                                                    (b) Sensitive to optical media opacities.
                                                                                                                                                                                                                                                                                                                             (c) Easily performed;\                                                                        
                                                                                                                                                                                                                                                                                                                             (d) Patient-friendly;\                                                                        
                                                                                                                                                                                                                                                                                                                             (e) Low variability;\                                                                         
                                                                                                                                                                                                                                                                                                                             (f) High reproducibility.                                                                     

  Doppler OCT                                     Visualization and quantification of blood flow *in vivo*.                                                                                                          \(a\) Significant reduction in the blood flow rate of the retina;\                                      \(a\) Rapid;\                                                                                 \(a\) No visualization of single cell;\
                                                                                                                                                                                                                     (b) Narrowing retinal blood column.                                                                     (b) Consistent;\                                                                              (b) Susceptible to ocular opacity.
                                                                                                                                                                                                                                                                                                                             (c) Economic;\                                                                                
                                                                                                                                                                                                                                                                                                                             (d) Non-invasive;                                                                             

  Retinal microperimetry                          Topographic correlation between fundus details and light sensitivity of macular function.                                                                          Retinal sensitivity correlated with brain neurodegeneration among type 2 diabetes patients.             \(a\) Non-invasive;\                                                                          Microperimety normative database in aging healthy controls and type 2 diabetic subjects without cognitive impairment is needed.
                                                                                                                                                                                                                                                                                                                             (b) Simple;\                                                                                  
                                                                                                                                                                                                                                                                                                                             (c) Fast;\                                                                                    
                                                                                                                                                                                                                                                                                                                             (d) Independent of the fixation and any other eye movement;\                                  
                                                                                                                                                                                                                                                                                                                             (e) Independent of mood or depressive disorders;\                                             
                                                                                                                                                                                                                                                                                                                             (f) High sensitivity;\                                                                        
                                                                                                                                                                                                                                                                                                                             (g) Cost-effectiveness.                                                                       

  **Animal studies**                                                                                                                                                                                                                                                                                                                                                                                                       

  Multiphoton microscopy                          Near-infrared light emitted by fluorescent dyes of AO1-987 and CRANAD-2.                                                                                           Detection of cerebral Aβ plaques in animal models.                                                      \(a\) High specificity;\                                                                      \(a\) Highly invasive;\
                                                                                                                                                                                                                                                                                                                             (b) Suitability for PET scan.                                                                 (b) Restricted fluorescent signal.

  Micron retinal imaging microscope               Visualization of fluorescence signals at high resolution and equipped with a 3-CCD camera, and specific set of filters suitable to detect curcumin fluorescence.   Dynamic pattern of plaque formation and clearance following immunotherapy.                              \(a\) Real-time;\                                                                             Humans studies are needed.
                                                                                                                                                                                                                                                                                                                             (b) High-resolution;\                                                                         
                                                                                                                                                                                                                                                                                                                             (c) Efficient;\                                                                               
                                                                                                                                                                                                                                                                                                                             (d) Low-cost;                                                                                 
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Structural Imaging Methods
==========================

Ocular Fundus or Retinal Photography
------------------------------------

Ocular fundus or retinal photography is the classic imaging technique for investigating the retina, providing routine retinal checks in eye clinics. Ocular fundus or retinal photography is able to detect three types of retinal vascular signs: (1) qualitative retinopathy and retinal arteriolar signs, (2) changes in retinal vascular caliber and (3) changes in global geometrical patterns of the retina ([@B17]).

Large number of studies have documented that qualitative retinal vascular signs and quantitative vascular measures, including retinopathy, vascular reduction, increasing variability of vessel width, attenuate complexity of branching characteristic, reduced optimality of the branching geometry and less tortuous venules, are associated with poorer cognitive performance based on different neuropsychological tests ([@B113]; [@B88]; [@B31]; [@B74]; [@B20]; [@B45]; [@B106]; [@B138]). The Rotterdam Study found that retinopathy was associated with AD in a cross-sectional population-based sample of individuals aged 55 years and older, whereas longitudinal data from the same study showed no association with incident AD ([@B128]). Retinopathy was not significantly associated with AD when investigated in the Cardiovascular Health Study ([@B5]) and the AGES-Reykjavik Study ([@B119]). With respect to AMD, [@B147] showed an association between the most advanced cases and AD, whereas the association was lost after adjustment for confounding variables. Similarly, [@B76] found that risk of AD increased for patients with advanced stage AMD after 25.2 months follow up. However, the association was not significant following adjustment for smoking and atherosclerosis. In terms of the morphology of the ONH, a significant correlation of the optic neuropathy with the onset, severity and duration of AD was confirmed previously ([@B142]; [@B55]). With CRAE as an index of vessel caliber, data from the three studies ([@B41]; [@B19]; [@B146]) were pooled and indicated a reduction in arteriolar width in AD. Increasing standard deviation of microvascular widths and microvascular attenuation in AD were found using different measures of arteriolar and venular caliber ([@B41]; [@B19]). Three case-control studies ([@B41]; [@B19]; [@B146]) examined the link between retinal geometric branching parameters, such as fractal dimensions, branching patterns and tortusity in AD patients. Findings from these studies reported consistent significant reduced venular, arteriolar, and total fractal dimensions, indicating a sparser network in AD (**Figure [1](#F1){ref-type="fig"}**). These studies have also consistently shown reduced complexity and optimality of the branching pattern. However, results of tortusity were mixed when compared AD patients with control subjects. In addition, AD patients' fundus images illustrated different patterns of RNFL abnormalities, including diffuse and wedge shape RNFL drop-out ([@B91]).

![Examples of **(left)** reduced retinal vascular fractal dimension, **(middle)** attenuation retinal venular caliber and increased retinal vascular tortuosity in AD patients, **(right)** normal retinal fundus photograph. Red: arterioles; blue: venules. The measured area of retinal vascular parameters was standardized as the region from 0.5 to 2.0 disk diameters away from the disk margin [@B19].](fnagi-10-00188-g001){#F1}

Current software programs for quantitative measurement of retinal vasculature in routine retinal image are not fully automated and therefore additional efforts are needed by technicians and clinicians. Novel software programs are being developed to fully automatically measure ocular fundus features such as calibers, tortuosity and network complexity, facilitating a more efficient assessment ([@B22]; [@B103]; [@B67]; [@B16]; [@B1]; [@B144]). In addition, with the advent of the non-mydriatic ultra-wide field retinal imaging technology, up to 200°, rather than the common 45° or 60°, of the retina can be captured in a single shot for investigating peripheral lesions ([@B72]), which may provide a more comprehensive picture of the overall retinal vascular structure and retina ([@B21]). A very recent pilot study using ultra-wide field retinal imaging identified peripheral biomarkers, including markedly increased drusen number, significant increase in venular width gradient and significant decrease in arterial fractal dimension, for AD and its progression over 2 years ([@B28]) (**Figure [2](#F2){ref-type="fig"}**).

![Grading of vascular parameters on ultra-wide field imaging. Dashed circles represent grading zone B: 0.5--1 OD diameter. C: 1--2 OD diameter. Turquoise lines: vascular fractal dimension; green dots: branching points; red line: arteriole; blue: venule ([@B28]).](fnagi-10-00188-g002){#F2}

It is noteworthy that the association between retinal changes with cognitive impairment and AD is weak and non-specific ([@B56]), partly due to the nature variation of retinal vascular parameters and common retinal lesions shared by many diseases, which may limit the usage of a single ocular fundus photography screening test for AD. However, it is possible that longitudinal analysis of retinal changes might be a potential tool to accurately detect preclinical AD or monitor AD. Further longitudinal studies are thus needed to explore this possibility and determine time course of retinal changes in AD.

Optical Coherence Tomography (OCT)
----------------------------------

Optical coherence tomography, a non-invasive technique providing high-resolution imaging of retina based on the principle of low coherence interferometry ([@B61]; [@B118]), has been extensively used to evaluate the morphological changes of the retina, such as peripapillary RNFL, macular thickness and volume, in AD. In line with the findings from post mortem studies, studies using OCT demonstrated a significant decline in peripapillary RNFL, and changes in macular thickness and volume in the eyes of patients that are progressive from MCI to AD. Results from two recent meta analysis ([@B24]; [@B140]) indicated that the attenuation in RNFL thickness, as observed in most studies, was significantly greater both in AD and MCI patients than that observed in the age-matched healthy controls. The mean RNFL thickness was confirmed to be reduced in AD and MCI patients in all quadrants ([@B109]; [@B62]; [@B107]; [@B73]; [@B68]; [@B75]; [@B4]; [@B116]; [@B50]), but some studies reported reduction of RNFL thickness predominantly in the superior ([@B109]; [@B62]; [@B9]; [@B73]; [@B68]; [@B95]; [@B4]; [@B116]; [@B50]) and inferior quadrants ([@B109]; [@B62]; [@B73]; [@B95]; [@B4]; [@B116]; [@B50]) (**Figure [3](#F3){ref-type="fig"}**). The retinal total thickness reduction in AD patients was also verified by different commercially available OCT devices ([@B95]). Additionally to the defects in the RNFL and total retinal thickness, reduction of total macular volume was also observed in AD patients and related to the severity of the disease based on the MMSE ([@B62]; [@B100]). There are, however, other studies having conflicting findings with the results described above ([@B107]; [@B73]; [@B75]; [@B82], [@B81]). With respect to the optic nerve analyzer, AD patients were more likely to show signs of optic neuropathy, such as optic disk atrophy, pathology optic disk cupping, and attenuation of the neuroretinal rim, when compared with age-matched healthy subjects ([@B142]; [@B55]).

![Example of peripapillary retinal nerve fiber layer (RNFL) thickness OCT measurements taken from the right eye of: a healthy control with all quadrants with **(A)** thickness normal for age, **(B)** a MCI patient with a decreased RFNL thickness in the temporal quadrant, and **(C)** a AD patient with decreased RFNL thickness in all quadrants. The line of graphic shows the RFNL thickness of the scanning circle as seen around the optic nerve head in the picture on the right. The colors represent normal distribution percentiles for age. Green: 95-5%; yellow: 5-1%; red: 1-0% ([@B4]).](fnagi-10-00188-g003){#F3}

More recently, OCT has evolved from older generations of TD-OCT to SD-OCT, which can capture 3D volume of retina with a higher scan speed, higher axial resolution and lower measurement variability ([@B84]). With this advance in OCT technology, precise evaluation of the sublayers of RGC is now available and moreover can be assessed using OCT automated segmentation algorithms ([@B129]). The GC-IPL, ganglion cell layer and photoreceptor layer can be visualized using SD-OCT. This may provide additional insights into the pathology of neurodegenerative conditions. Changes in the macular GC-IPL and, macular ganglion cell complex (includes RNFL, ganglion cell layer and IPL) and photoreceptor layer are more sensitive reflections of neurodegenerative disease than the peripapillary RNFL reduction ([@B137]; [@B102]), since macular is the area with greatest density of cone photoreceptors cells and RGCs. Therefore, several recent studies have reported changes of specific retinal layers at the macular region in AD and supported the macular GC-IPL thinning being a new marker for detection of neurodegenerative damage in early AD and MCI ([@B46]; [@B7]; [@B18]; [@B42]). Two recent studies using the improved OCT indicated significant reductions in macular GCC in AD patients than the age-matched healthy controls ([@B95]; [@B7]). When compared to patients with periperpillary RNFL axonal loss, patients with MCI were more specifically present with reduced macular GC-IPL ([@B18]). The first prospective and longitudinal study found the attenuation of macular RNFL might be the earliest anatomic marker of retinal neuronal loss in the preclinical stage of AD and such loss accounted for approximate 10% of the variance in neocortical amyloidosis observed by PET imaging ([@B126]).

Limitations of these technologies should be noted when interpreting the potential utility of OCT in AD management. First, ocular opacity, such as cataract, has profound impacts on the quality of the imaging. However, newer imaging methods, such as Swept source (SS)-OCT, could overcome this limiting factor, since SS-OCT offers additional advantages over SD-OCT in penetration depth and therefore reduced sensitivity to ocular opacity ([@B37]). Second, instrument variability and different protocols in studies may hinder the comparability between different studies. It should be noted that meta analysis of the different commercial OCT results might be offset to statistical differences in the retinal structural changes. Therefore, standardized OCT protocol to study AD is needed in the near future. Third, structural changes in retina observed in AD patients may be non-specific to AD and shared by other ocular diseases, such as decreased RNFL in glaucoma. Nevertheless, combination OCT measurements of structural changes in retina and other biomarkers could potentially be a valuable approach in AD diagnosis and prognostication.

Confocal Scanning Laser Ophthalmoscopy (cSLO)
---------------------------------------------

Confocal scanning laser ophthalmoscopy is an imaging technique and allows for reconstructing three-dimensional structures with advantages of increasing resolution and contrast. Morphological changes in the ONH measured by cSLO, including a significant reduction in the RNFL, neuroretinal rim, and increased vertical cup-to-disk, were found in AD patients in comparison to healthy subjects ([@B29]). In contrast to this finding, a recent study using cSLO did not document significant difference in the ONH between AD patients and healthy controls ([@B83]). However, AD patients could be differentiated from glaucoma patients, implying the potential utility of cSLO as a new biomarker to recognize specific neurodegenerative diseases ([@B83]). Using a lipid curcumin fluorochome and a modified point cSLO, a recent study reported the increased burden of retinal amyloid deposits in live AD patients, which might lead to a practical approach for large-scale AD screening and monitoring ([@B77]).

Detection of Apoptotic Retinal Cells (DARC)
-------------------------------------------

Detection of apoptotic retinal cells is a novel imaging technology that can monitor RGC apoptosis. Although RGCs can not be real-time visualized without a marker, it has been indicated that DARC is a useful tool to detect RGC apoptosis *in vivo* in experimental animal models ([@B26], [@B25]; [@B54], [@B53]; [@B92]) (**Figure [4](#F4){ref-type="fig"}**). Combined with fluorescein labeled annexin V and a cSLO, DARC allows for visualization of single RGCs undergoing apoptosis. Using DARC imaging, the number of apoptotic RGCs in a AD model significantly increased, which became even worse under oxidative stress when compared to healthy controls ([@B25]). Furthermore, intraocular administration of extraneous Aβ peptides can lead to considerable RGC apoptosis *in vivo*, which can be treated and reserved by drugs targeting Aβ pathway ([@B53]). This finding promises the potential of assessing treatment effectiveness and screening new drugs by the means of DARC ([@B54], [@B53], [@B51]; [@B125]). Accordingly, although there is no study investigating the efficacy of DARC in patients with AD, a Phase I clinical trial of using DARC (ISRCTN59484478) in healthy and glaucoma subjects has recently been completed and DARC is believed to be used as a valuable tool in early diagnosis and treatment assessment for AD.

![Example of detection of apoptotic retinal cells (DARC) in a rat model ([@B26]).](fnagi-10-00188-g004){#F4}

Functional Imaging Methods
==========================

Pattern Electroretinogram (PERG)
--------------------------------

Pattern electroretinogram allows to objectively assess ganglion cells and their axons' electrical response to patterned stimuli ([@B94]; [@B69]; [@B141]). Several studies have consistently reported abnormal PERG in AD patients, such as a significant reduction in the amplitude of ERG responses and an attenuation of the ERG signal ([@B69]; [@B141]; [@B109]), further suggesting the evidence of retinal ganglion cell dysfunction related to the structural changes in the RNFL of AD patients ([@B109]; [@B108]). However, conflicting results were also demonstrated in other studies revealing normal ERG responses in mild to moderate AD ([@B136]; [@B71]). Nevertheless, PERG can be useful in early phase of the AD, when RGC dysfunction and optic nerve alteration are already existed ([@B80]) (**Figure [5](#F5){ref-type="fig"}**). However, PERG is quite cumbersome and time-consuming, which may limit its broad availability and utility.

![Example of PERG-P50-wave latency delay and reduced amplitudes of P50- and N95-wave in a patient with the early stage of Alzheimer's disease (below) in comparison with the normal control (above) ([@B80]).](fnagi-10-00188-g005){#F5}

Retinal Oximetry
----------------

Retinal oximetry is a spectrophotometric fundus imaging to measure oxygen saturation in retinal blood vessels in a non-invasive, fast and safe manner([@B65]). Retinal oximetry can reliably and repeatedly detect changes in oxygen metabolism to reflect metabolic and functional changes in retina ([@B149]). Due to the availability of the retinal oximetry to clinical researchers in the past decade, retinal oximetry has offered new insights into several retinal diseases, such as diabetic retinopathy, glaucoma, as well as diseases of the brain, including AD ([@B135]). [@B36] were the first to report oximetry abnormalities in retinas of AD patients compared with a healthy cohort. These findings have recently been confirmed and extended to patients with MCI ([@B105]) (**Figure [6](#F6){ref-type="fig"}**). Further studies are needed to confirm and expand the utility of retinal oximetry in AD clinical practice and trials.

![Example of fundus oximetry images from (above) a age-adjusted healthy individual and (below) an mild cognitive impairment patient ([@B105]).](fnagi-10-00188-g006){#F6}

Doppler OCT
-----------

As one of the functional extensions of OCT, Doppler OCT aims to visualize and quantify blood flow *in vivo*. Significant reduction in the blood flow rate of the retina and narrowing retinal blood column had been identified through Doppler OCT in patients with AD when compared with control subjects ([@B9]), verifying the potential association between changes of blood flow in the retina and the brain. The decreased perfusion both in the retina and the brain may affect ATP synthesis and cause oxidative stress, which resulted in neuronal death ([@B122]). Doppler OCT has been shown the potential to improve the ability to diagnose and monitor AD through ocular vascular changes.

Retinal Microperimetry
----------------------

Retinal microperimetry is a simple, non-invasive and fast test that measures the topographic correlation between fundus details and light sensitivity for macular function ([@B121]; [@B2]) (**Figure [7](#F7){ref-type="fig"}**). Independent of the fixation and any other eye movement, retinal microperimetry is a strong candidate examination for monitoring AD. It has been indicated that retinal sensitivity evaluated by retinal microperimetry correlated with brain neurodegeneration and could be a novel biomarker for predicting the risk of developing AD among type 2 diabetes patients ([@B23]). Some recent studies have documented more sensitivity of microperimetry in identifying early functional changes of the retina than ERG ([@B148]). Therefore, retinal microperimetry might be a cost effective way of managing the diagnosis and progression of AD in the future.

![Example of a normal individual measurement from (above) Humphrey Field Analyzer (10-2 pattern, SITA Standard) and (below) MP-1 microperimetry (10-2 pattern, 4-2 strategy) (Acton et al., 2013).](fnagi-10-00188-g007){#F7}

Studies in Animal Models
========================

Some of the promising retinal imaging technologies have been applied and tested in animal models. In a mice model expressing human mutant P301S tau, aggregation and progression of fibrillar tau in the retina were detected by cSLO over several months ([@B127]). This technique may be suitable to manage therapeutic interventions aimed at reducing fibrillar tau aggregation in the retina. Using fluorescent dyes AO1-987 and CRANAD-2 which can emit near-infrared light, multiphoton microscopy has been used to detect cerebral Aβ plaques in AD animal models ([@B57]). Despite of high specificity and suitability in PET scan ([@B120]), this technique is highly invasive and a cranial window is needed ([@B32]). Moreover, fluorescent signal is limited on the cortical surface ([@B98]). Micron II retinal imaging microscope was used *in vivo* to document dynamic pattern of plaque formation and clearance following immunotherapy ([@B77]). This technology may be a useful tool to monitor progression and assess therapy efficiency in AD patients.

Future Directions
=================

Even though the current findings and applications of retinal imaging in AD patients offer a promising future, however, there are still several gaps to be filled in the future research. First, the underlying mechanisms between retinal changes and AD have not been completely elucidated, which may hinder the translation of retinal imaging into a valuable tool in AD clinical practice. Future experimental research that explores the etiology of AD and biological mechanism between retinal changes and AD is needed to facilitate the utility of retinal imaging in AD patients. Second, studies with large sample size and long-term follow-up are needed to clarify longitudinal retinal changes and its relation to AD, thus building prediction models to identify the patients at risk of developing AD. Third, a large number of novel retinal imaging technologies have been used to estimate the structure and functions of the retina, such as OCT-angiography, and retinal function imager. Very recent work has used OCT-angiography in AD patients and provided promising results that significant decreased retinal vascular density and enlarged foveal avascular zone were observed in AD group compared with the control group ([@B14]). Further studies are needed to confirm the utility and assess the cost-effectiveness of such newer technologies in AD monitoring. Furthermore, the diagnostic and prognostic values of combining different retinal imaging technologies with neurological examinations should be investigated for the further development of multimodel for clinical use. Finally, inclusion of different types of dementia, such as Lewy body dementia, to the clinical trial is important to clarify the specific clinical implications of retinal imaging technologies in AD patients. In addition, some neurodegenerative brain disorders, such as Parkinson's disease, have also shown morphological evidence of disruption of retinal structure and function ([@B3]). Understanding neurodegeneration in the retina may provide not only a clearer picture of brain disorders' onset and progression, but also promising non-invasive tools for large-scale screening and monitoring brain diseases.

Conclusion
==========

Structural and functional retinal changes have been suggested as the window to the neurodegenerative diseases. Retinal imaging is a non-invasive, cost-effective and highly promising method to study AD and provides new and additional important insights into AD. Future studies investigating underlying mechanisms between retinal changes and AD and the utility of combining retinal imaging technologies with neurological examinations are needed before retina imaging can be translated as a useful tool in clinical practice.
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Aβ

:   amyloid-β

AβPP

:   amyloid-β precursor protein

AD

:   Alzheimer's disease

AMD

:   age-related macular degeneration

BBB

:   blood-brain barrier

BRB

:   blood-retinal barrier

CFS

:   cerebrospinal fluid

CNS

:   central nervous system

CRAE

:   central retinal arterial equivalent

cSLO

:   confocal scanning laser ophthalmoscopy

DARC

:   detection of apoptotic retinal cells

GC-IPL

:   ganglion cell-inner plexiform layer

GCC

:   ganglion cell complex

MAP

:   microtubule-associated protein

MCI

:   mild cognitive impairment

MMSE

:   mini mental state examination

MRI

:   magnetic resonance imaging

OCT

:   Optical coherence tomography

ONH

:   optic nerve head

PERG

:   pattern electroretinogram

PET

:   positron emission tomography

PWV

:   pulse wave velocity

RGCs

:   retinal ganglion cells

RNFL

:   retinal nerve fiber layer

SD-OCT

:   spectral-domain OCT

SS-OCT

:   swept source OCT

TD-OCT

:   time-domain OCT
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